Macquarie Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.6M | Sell |
423,717
-25,118
| -6% | -$1.64M | 0.03% | 575 |
|
|
2025
Q1 | $30.1M | Sell |
448,835
-113,768
| -20% | -$7.62M | 0.04% | 545 |
|
|
2024
Q4 | $31.1M | Buy |
562,603
+70,956
| +14% | +$3.92M | 0.04% | 543 |
|
|
2024
Q3 | $29.3M | Buy |
491,647
+103,570
| +27% | +$6.18M | 0.03% | 588 |
|
|
2024
Q2 | $24.7M | Buy |
388,077
+174,178
| +81% | +$11.1M | 0.03% | 609 |
|
|
2024
Q1 | $14.8M | Sell |
213,899
-16,163
| -7% | -$1.12M | 0.02% | 741 |
|
|
2023
Q4 | $12.7M | Buy |
+230,062
| New | +$12.7M | 0.01% | 775 |
|
|
2018
Q4 | – | Sell |
-200
| Closed | -$11K | – | 2244 |
|
|
2018
Q3 | $11K | Buy |
+200
| New | +$11K | ﹤0.01% | 1980 |
|